Trends in Alzheimer Imaging & Management

Jennifer Matsui, a 4th-year medical student at Ohio State, and Memorial Sloan Kettering’s Dr. Kaitlyn Lapen, discuss confusion and solutions surrounding SBRT vs SABR terminology and its impact on metastatic cancer treatment decisions.

Lapen K, Mathis NJ, Tsai CJ, Yang JT, Gillespie EF. SBRT vs SABR: Does terminology
differentiate treatment intent in metastatic cancer? Appl Radiat Oncol. 2021;10(4)6-10.

https://appliedradiationoncology.com/articles/stereotactic-body-radiation-therapy-sbrt-vs- stereotactic-ablative-radiation-therapy-sabr-does-terminology-differentiate-treatment-intent-in- metastatic-cancer

Jana Kobeissi, a 4th-year medical student at the American University of Beirut, talks with Kent Wallner, MD, a brachytherapy expert at UW Medicine, about coronary brachytherapy’s pathophysiology, target and dose uncertainties, dose response considerations, collaboration challenges, and future.

Wallner K, Kim M, Kearney KE, et al. The evidence and rationale for a coronary brachytherapy dose-response. Appl Radiat Oncol. 2022;11(3):18-26.
https://appliedradiationoncology.com/articles/the-evidence-and-rationale-for-a-coronary-brachytherapy-dose-response

Ellie Thompson, a 4th-year medical student at the University of South Carolina, Columbia, talks with Steven Octavianus, MD, PhD, a radiation oncologist in Jakarta, Indonesia, about rising cancer incidence in Indonesia, the need for greater access to radiation therapy (RT) centers, and hypofractionation a useful innovation in overcoming RT shortages.

Article: Octavianus S, Gondhowiardjo S. Radiation therapy in Indonesia: estimating demand as part of a national cancer control strategy. 
Appl Radiat Oncol. 2022;11(1)35-43.